Clinically relevant improvements in asthma-related quality of life in patients receiving omalizumab as add-on therapy

被引：1
|
作者：
Busse, W
Fox, H
Surrey, K
Maykut, R
Reisner, C
机构：
[1] Univ Wisconsin, Dept Med, Madison, WI 53706 USA
[2] Novartis Horsham Res Ctr, Horsham, W Sussex, England
[3] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.12.033
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
30
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Effect of Omalizumab as Add-On Therapy on Asthma-Related Quality of Life in Severe Allergic Asthma: A Brazilian Study (QUALITX)
    Rubin, A. S.
    Souza-Machado, A.
    Andradre-Lima, M.
    Ferreira, F.
    Honda, A.
    Matozo, T. M.
    JOURNAL OF ASTHMA, 2012, 49 (03) : 288 - 293
  • [2] Omalizumab improves asthma-related quality of life in patients with severe allergic asthma
    Finn, A
    Gross, G
    van Bavel, J
    Lee, T
    Windom, H
    Everhard, F
    Fowler-Taylor, A
    Liu, J
    Gupta, N
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (02) : 278 - 284
  • [3] Omalizumab improves asthma-related quality of life in children with allergic asthma
    Lemanske, RF
    Nayak, A
    McAlary, M
    Everhard, F
    Fowler-Taylor, A
    Gupta, N
    PEDIATRICS, 2002, 110 (05) : e55
  • [4] Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
    da Cunha, Fernanda Sales
    Rodrigues Valle, Solange Oliveira
    Elabras Filho, Jose
    Dortas Junior, Sergio Duarte
    Franca, Alfeu Tavares
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2018, 44 (05) : 439 - 441
  • [5] The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma
    Buhl, R
    Hanf, G
    Solèr, M
    Bensch, G
    Wolfe, J
    Everhard, F
    Champain, K
    Fox, H
    Thirlwell, J
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) : 1088 - 1094
  • [6] Omalizumab as add-on therapy in a patient with severe asthma and OSA
    Scioscia, Giulia
    Buonamico, Enrico
    Foschino Barbaro, Maria Pia
    Lacedonia, Donato
    Sabato, Roberto
    Carpagnano, Giovanna Elisiana
    RESPIROLOGY CASE REPORTS, 2020, 8 (02):
  • [7] Efficacy of omalizumab therapy in asthma patients with or without asthma-related and allergic comorbidities
    Chen, M.
    Choo, E.
    Yoo, B.
    Raut, P.
    Haselkorn, T.
    Pazwash, H.
    Holweg, C. T. J.
    Hudes, G.
    ALLERGY, 2019, 74 : 36 - 36
  • [8] Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma
    Jung, Jae-Woo
    Park, Hae-Sim
    Park, Choon-Sik
    Cho, Sang-Heon
    Choi, Inseon S.
    Moon, Hee-Bom
    Kwon, Soon Seog
    Yoon, Ho Joo
    Park, Jung Won
    Lee, Jong-Myung
    Choi, Dong-Chull
    Choi, Byoung Whui
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (04): : 1001 - 1013
  • [9] Symptom control and improved functioning: The effect of omalizumab on asthma-related quality of life (ARQL)
    Luskin, AT
    Kosinski, M
    Bresnahan, BW
    Ashby, M
    Wong, DA
    JOURNAL OF ASTHMA, 2005, 42 (10) : 823 - 827
  • [10] Omalizumab is an effective add-on therapy in moderate-to-severe allergic asthma
    不详
    Drugs & Therapy Perspectives, 2005, 21 (7) : 1 - 5
12345